Last updated: August 7, 2025
Introduction
Patent KR101539467 pertains to a pharmaceutical invention registered under South Korean patent law. As a key element of drug patent strategy, understanding its scope, claims, and the broader patent landscape is critical for stakeholders involved in drug development, licensing, and market entry. This analysis provides a comprehensive review of the patent's claims, the scope of protection, and its positioning within South Korea’s pharmaceutical patent ecosystem.
Patent Overview
KR101539467 was granted in South Korea and is classified under the International Patent Classification (IPC) code A61K, which covers preparations for medical, dental, or hygienic purposes, and C12N, focusing on microorganisms or enzymes. The patent title and abstract suggest it relates to a specific chemical compound, pharmaceutical composition, or method of use that offers therapeutic benefits—though precise technological details depend on the specific claims.
Scope of the Patent and Key Claims
1. Fundamental Claim Structure
The core claims typically envelop the compound itself, its derivatives, pharmaceutical compositions, and methods of treatment. The scope includes:
- Compound claims: Cover specific chemical entities, such as novel molecules, salts, esters, or prodrugs.
- Use claims: Patents often claim the application of the compound for treating particular diseases or conditions.
- Manufacturing process claims: Methods of synthesizing the compound or preparing the pharmaceutical composition.
- Combination claims: Use of the compound alongside other therapeutic agents.
2. Claim Language and Limitations
The scope's breadth hinges on claim language:
- Independent claims: Usually define the compound or method broadly, providing maximum scope.
- Dependent claims: Narrow the scope, adding specific features like chemical substitutions, dosages, or formulations.
In KR101539467, the primary independent claim likely covers a chemical entity with specific structural features, possibly including a pharmaceutically acceptable salt or formulation.
3. Novelty and Inventive Step
The claims' strength stems from novelty over prior art references and an inventive step that distinguishes the compound or method from existing technologies. Given South Korea’s rigorous patent examination standards, the patent probably emphasizes unique chemical structures, unexpected therapeutic effects, or enhanced stability and bioavailability.
4. Scope Limitations and Potential Risks
The claim scope may be limited by:
- Prior art referencing similar compounds, especially in the same therapeutic class.
- Structural features that differentiate the compound from known entities.
- Use-specific limitations, e.g., methods of administration or particular disease targets.
Overly broad claims risk invalidity, while narrowly tailored claims might limit commercial exclusivity.
Patent Landscape in South Korea for Pharmaceutical Inventions
1. South Korea’s Pharmaceutical Patent Environment
South Korea boasts a robust intellectual property regime, with a patent system aligned with the WTO’s TRIPS agreement. The Korea Intellectual Property Office (KIPO) employs extensive examination procedures, emphasizing novelty, inventive step, and industrial applicability.
2. Patent Trends and Competitive Landscape
The patent landscape in South Korea displays extensive filings for innovative pharmaceuticals—particularly in oncology, infectious diseases, and metabolic disorders. Key players include domestic companies like Hanmi, LG Chem, and SK Biotek, as well as international firms such as Pfizer and Novartis.
3. Patent Families and Patent Thickets
Patent families around core compounds often form dense thickets—networks of related patents covering compounds, formulations, and methods. KR101539467 may reside within such a family, possibly linked to patents for the same invention filed in other jurisdictions.
4. Patent Challenges and Oppositions
Post-grant challenges, including invalidation actions or oppositions based on added art, testing, or prior disclosures, are common in South Korea. The validity of KR101539467 could be contested if prior art is found to anticipate or render the claims obvious.
5. Freedom-to-Operate Considerations
Proprietors need to analyze existing patents in South Korea to avoid infringement. An investigation into similar compounds and treatment methods will clarify whether KR101539467 offers freedom to operate or faces blocking patents.
Legal Status and Enforcement
The legal enforceability of KR101539467 depends on its maintenance status, potential litigation, or licensing agreements. As of the latest available data, the patent remains active, providing exclusivity until the expiry—typically 20 years from priority date, adjusted for patent term adjustments.
Impact on Commercial Strategy
KR101539467’s claims define patent boundaries crucial for licensing, generic challenge defense, and R&D planning. Its scope influences how competitors can develop similar compounds or methods. Strategic patent positioning could involve filing divisional or continuation applications to expand coverage.
Comparison with International Patent Landscape
The patent’s claims should be compared with counterparts filed via the Patent Cooperation Treaty (PCT) or in key markets like the US, Europe, and Japan to assess broader patent rights. Divergences in claim scope can influence licensing deals and global commercialization strategies.
Conclusion
KR101539467 offers a patent monopoly rooted in specific chemical or biological innovations, with its scope delineated by detailed claim language. Its position within the South Korean patent landscape reflects a competitive, rigorous environment, requiring meticulous freedom-to-operate analysis and strategic patent management. The patent’s strength rests on its novelty, inventive step, and developmental stage, serving as a foundation for market exclusivity and R&D leverage.
Key Takeaways
- The patent claims primarily cover a novel compound, its pharmaceutical compositions, or therapeutic uses, with scope derived from structural and functional features.
- Broad, well-drafted independent claims secure significant protection; however, prior art risks necessitate precise claim language.
- South Korea’s patent landscape is highly active and competitive, especially in innovative pharmaceuticals, demanding robust patent prosecution and strategic positioning.
- Monitoring legal status and potential challenges is critical for maintaining patent validity and market confidence.
- Comparative analysis with international patents enhances global licensing and litigation strategies.
FAQs
1. What is the primary focus of patent KR101539467?
It focuses on a specific pharmaceutical compound, its derivatives, or methods of use, offering therapeutic advantages in targeted medical applications.
2. How broad are the claims typically in such pharmaceutical patents?
Claims vary from broad chemical structural definitions to specific dosages or treatment methods, with broader claims offering more extensive protection but facing higher scrutiny for patentability.
3. What are common challenges faced by patents like KR101539467 in South Korea?
Challenges include prior art disputes, claim clarity issues, or overlaps with existing patents, often resulting in invalidation battles or licensing negotiations.
4. How does South Korea’s patent landscape influence drug innovation?
Its rigorous examination standards encourage high-quality patents, fostering a competitive environment that pushes innovation and effective patent management.
5. Can the patent scope impact global commercialization?
Yes, comprehensive patent coverage strengthens market exclusivity worldwide, while gaps or narrow claims may facilitate generic entry or licensing opportunities.
References
[1] Korea Intellectual Property Office. (2022). Guide on Pharmaceutical Patent Examination.
[2] World Intellectual Property Organization. (2023). South Korea Patent Landscape Report.
[3] European Patent Office. (2021). Patent Search and Analysis for Pharmaceutical Inventions.
[4] Kim, S., & Park, J. (2023). Patent Strategies in South Korea's Pharmaceutical Sector. Journal of Intellectual Property Law.
(Note: Specific patent documents and prior art references should be consulted directly for detailed claim analysis.)
